Impact of the shift to a fibrinolysis-first strategy on care and outcomes of patients with ST-segment–elevation myocardial infarction during the COVID-19 pandemic—The experience from the largest cardiovascular-specific centre in China.

MLA

Leng, Wen-Xiu, et al. “Impact of the Shift to a Fibrinolysis-First Strategy on Care and Outcomes of Patients with ST-Segment–elevation Myocardial Infarction during the COVID-19 Pandemic—The Experience from the Largest Cardiovascular-Specific Centre in China.” International Journal of Cardiology, vol. 329, Apr. 2021, pp. 260–65. EBSCOhost, https://doi.org/10.1016/j.ijcard.2020.11.074.

APA

Leng, W.-X., Yang, J.-G., Li, X.-D., Jiang, W.-Y., Gao, L.-J., Wu, Y., Yang, Y.-M., Yuan, J.-Q., Yang, W.-X., Qiao, S.-B., & Yang, Y.-J. (2021). Impact of the shift to a fibrinolysis-first strategy on care and outcomes of patients with ST-segment–elevation myocardial infarction during the COVID-19 pandemic—The experience from the largest cardiovascular-specific centre in China. International Journal of Cardiology, 329, 260–265. https://doi.org/10.1016/j.ijcard.2020.11.074

Chicago

Leng, Wen-Xiu, Jin-Gang Yang, Xiang-Dong Li, Wen-Yang Jiang, Li-Jian Gao, Yuan Wu, Yan-Min Yang, et al. 2021. “Impact of the Shift to a Fibrinolysis-First Strategy on Care and Outcomes of Patients with ST-Segment–elevation Myocardial Infarction during the COVID-19 Pandemic—The Experience from the Largest Cardiovascular-Specific Centre in China.” International Journal of Cardiology 329 (April): 260–65. doi:10.1016/j.ijcard.2020.11.074.